1.
Epidermal growth factor polymorphism most prevalent in stage II cervical carcinoma. Univ Med [Internet]. 2014 Dec. 2 [cited 2025 Apr. 3];33(3):192-8. Available from: https://univmed.org/ejurnal/index.php/medicina/article/view/31